High BMI at time of diagnosis has no effect on clinical outcomes for HER2-positive breast cancer
Intended for healthcare professionals
Journal scan Previous     Next

High BMI at time of diagnosis has no effect on clinical outcomes for HER2-positive breast cancer

Dion Smyth Lecturer-practitioner, Cancer and palliative care, Birmingham City University

In contrast with previous findings, a retrospective cohort study carried out in Italy has found no negative effect of body mass index (BMI) at the time of diagnosis on clinical outcomes for patients with HER2-positive metastatic breast cancer.

Cancer Nursing Practice. 17, 2, 12-12. doi: 10.7748/cnp.17.2.12.s10

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or